Skip to main content
. 2019 Jul 11;17(7):411. doi: 10.3390/md17070411

Table 3.

In-vitro antiproliferative activity of isolated metabolites (1–7) against MCF-7 cells.

Tested Compound IC50 ± S.D. (µg/mL) a
1 23.84 ± 0.2
2 26.22 ± 0.1
3 26.81 ± 0.2
4 25.28 ± 0.3
5 27.2 ± 0.5
6 24.97 ± 0.3
7 22.39 ± 0.2
Doxorubicin 12.78 ± 0.3

a Values are a mean of 3 independent experiments.